PS3 KEYNOTE-024 Update: Pembrolizumab Vs Platinum-Based Chemotherapy for Advanced NSCLC with PD-L1 Tumor Proportion Score ≥50%
Journal of Thoracic Oncology(2018)
关键词
pembrolizumab,nonesmall-cell lung cancer,overall survival,KEYNOTE-024
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要